Our findings are in agreement with those of a study by Prensner et al. (2011), which investigated PCAT-1 expression in prostate cancer and found that the overexpression of PCAT-1 was associated with prostate cancer progression [11]. This evidence concerns the gene PCAT1 and prostate carcinoma.